Effects of tiotropium combined with either salmeterol or salmeterol/fluticasone in moderate to severe COPD

Primary Care Respiratory Journal

Volumn 16, Issue 4, 2007, Pages 258-260

  Kaplan, Alan ^a  

^a Family Physician Airways Group of

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; PLACEBO; SALMETEROL; TIOTROPIUM BROMIDE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOTE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 34548015240     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.3132/pcrj.2007.00055     Document Type: Note

References (1)

1. Calverley PM, Anderson JA, Celli B et al; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89.